Skip to main content

Table 1 Anthropometric and metabolic characterisitcs of study participants

From: Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism

Variables

All(n = 120)

CAD(n = 68)

Non-CAD(n = 52)

P value

Male(%)

60.80

60.29

61.54

NS

Age(years)

64.17 ± 8.11

65.13 ± 8.03

63.91 ± 8.06

NS

BMI(kg/m2)

24.43 ± 3.81

24.49 ± 4.57

24.47 ± 3.21

NS

TG(mg/dL)

117.8(87.7–174.5)

120.9(91.5–168.1)

113.4(87.7–182.5)

NS

TC(mg/dL)

155.1(133.0–184.8)

146.6(128.5–183.3)

160.9(133.0–181.0)

NS

HDL-C(mmol/L)

1.09 ± 0.25

1.05 ± 0.25

1.12 ± 0.26

NS

LDL-C(mmol/L)

2.54 ± 0.80

2.40 ± 0.74

2.48 ± 0.82

NS

ApoAI(g/L)

1.13 ± 0.20

1.11 ± 0.19

1.16 ± 0.20

NS

ApoB(g/L)

0.92 ± 0.26

0.89 ± 0.26

0.88 ± 0.27

NS

FFA (mmol/L)

0.48 ± 0.28

0.51 ± 0.29

0.42 ± 0.26

0.026

hsCRP(mg/L)

2.73(1.00–8.98)

2.64(0.71–10.46)

2.30(0.87–4.64)

NS

BUN(mmol/L)

5.91(4.84–7.23)

5.70(4.35–7.30)

6.28(5.32–7.96)

NS

UA(umol/L)

308.1(280.0–405.5)

305.8(283.3–370.9)

341.0(292.1–430.1)

0.054

CR(umol/L)

74.50(57.20–86.30)

77.15(67.68–84.68)

77.90(58.98–98.40)

NS

Diabetes(%)

21.67

32.35

7.69

0.001

Statin use(%)

36.67

54.41

13.46

< 0.0001

  1. Values are expressed as mean ± SD or median (interquartile range). CAD indicates coronary artery disease; BMI body mass index, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein-cholesterol; LDL-C low density lipoprotein-cholesterol; apoAI apolipoprotein AI, apoB apolipoprotein B, FFA free fatty acid, hsCRP high sensitivity C reactive protein, BUN blood urea nitrogen, UA uric acid, CR creatinine, apoCIII apolipoprotein CIII